Ex-Hindustan Coca-Cola CEO Leads Funding Round for Health Care Startup Varco®

Ex-Hindustan Coca-Cola CEO Leads Funding Round for Health Care Startup Varco

Carbonated Cola to cutting-Edge Care: Ex-Hindustan Coca-Cola CEO unleashes investment magic on Varco®.

Indian-based health care startup Varco® Leg Care has successfully raised an undisclosed amount in a seed round of funding led by former CEO of Hindustan Coca-Cola, Neeraj Garg. Other prominent investors include Dr. Mohit Lalvani from Mascot Spincontrol India Pvt Ltd, a renowned medical consultant, and Simple Juneja, a global business leader with experience at companies such as Coca-Cola, Bacardi and LVMH. The funding round also attracted several angel investors from medical, consultant companies, FMCG and infrastructure sectors.

Varco® Leg Care has outlined its strategic plan to utilize the recent funding for product expansion, specifically targeting leg health improvement. The company aims to leverage advanced technology to enhance customer retention and increase market visibility, while simultaneously strengthening its distribution networks. Varco® also intends to attract prominent figures in key markets to further establish its brand presence, expand its operations in the U.S. and the United Arab Emirates and allocate significant resources to research and development initiatives.

Neeraj Garg, former CEO of Hindustan Coca-Cola, expressed his confidence in the product’s commercial potential. He said that the product has undergone rigorous scientific research in India, the U.S. and Europe. He also noted that the company’s online presence is steadily growing and that their ultimate goal is to establish distribution channels, from direct-to-consumer to a blended physical and digital model. Garg believes that within the next three to four years, the brand has the potential to generate US$10 million in revenue.

Mr. Anondeep Ganguly, CEO of Varco® Leg Care, highlighted the company’s commitment to research and development in creating a pioneering phyto-based leg care brand in Asia. Dr. Apurba Ganguly, the Chief Scientific Officer, has played a pivotal role in leading this initiative, boasting an impressive track record of over 100 clinical studies published in esteemed medical journals. Dr. Ganguly is also a distinguished member of the American Academy of Pain Medicine and the European Medical Association. Varco® Leg Care aims to establish itself as the foremost brand in the industry by prioritizing the specific needs of leg care.

The company expressed their pride in the appointment of Dr. Tapish Sahu as their Chief Medical Advisor, highlighting his expertise as one of the country’s leading Vascular Surgeons. Ganguly emphasized that Dr. Sahu’s guidance will be invaluable in the development of their product range, enabling them to cater to various conditions such as varicose veins, diabetic feet and nail fungus. Varco® Leg Care aims to leverage advanced formulations and proprietary phytotransdermal technology to offer cutting-edge solutions for end-to-end leg health challenges. 

Established in 2022, Varco® Leg Care, a specialized leg care solutions provider, has quickly gained recognition and achieved the significant milestone of being listed on Walmart’s platform. Demonstrating consistent growth, Varco® Leg Care has maintained a month-over-month growth rate of 30%.

Varco® Leg Care is dedicated to expanding its leg care product range and enhancing its presence in the U.S. market through partnerships with major marketplaces. The company’s goal is to further extend its retail presence based on data-driven strategies, with the aim of establishing a dominant position in the leg care section of pharmacies globally. These plans reflect Varco® Leg Care’s long-term vision and commitment to providing innovative and effective products to customers worldwide.

Also read:

Header image courtesy of Varco® Leg Care


Share on facebook
Share on twitter
Share on linkedin
Share on email